xvi AMER‹KAN PS‹K‹YATR‹ B‹RL‹⁄‹ PS‹K‹YATR‹ ‹Ç‹N KURUL SINAVLARI HAZIRLIK VE GÖZDEN GEÇ‹RME KILAVUZU Squibb, Eli Lilly, Cyberonics, Neuronetics, National Institute of Mental Health, Stanley Foundation; Consultant/Honoraria: Eli Lilly, GlaxoSmithKline, Cyberonics, Pfizer, Medtronic, Forest, Aspect Medical Systems, Novartis. James M. Martinez, M.D.—Research Support: Aspect Medical Systems, AstraZeneca, Bristol-Myers Squibb, Cyberonics, Eli Lilly, Forest Pharmaceuticals, Neuronetics, Sanofi-Aventis, National Institute of Mental Health, Stanley Foundation; Speakers’ Bureau: AstraZeneca, Bristol-Myers Squibb, Cyberonics, Eli Lilly, Forest Pharmaceuticals, GlaxoSmithKline, Janssen, Pfizer, Wyeth Ayerst; Consultant: Cyberonics. Melissa Martinez, M.D.—Research Support: Cyberonics, Eli Lilly, Sanofi-Aventis, Aspect Medical Systems, Bristol-Myers Squibb, Neuronetics. Andrew H. Miller, M.D.—Grants/Research Support: National Institute of Mental Health, National Heart, Lung and Blood Institute (NHLBI), GlaxoSmithKline, Janssen, Schering-Plough. Consultant: Centecor, Schering-Plough Michael J. Minzenberg, M.D.—Research Support: Elan, Cephalon. Ziad H. Nahas, M.D., M.S.C.R.—Grant Support: National Institute of Mental Health, Neuronetics, Cyberonics, Medtronic, Eli Lilly, Neurospace; Consultant: Neuronetics, Cyberonics, Avanir Pharmaceutical, Aventis Pharmaceutical, Neuropace; Speakers’ Bureau: Cyberonics. Jeffrey H. Newcorn, M.D.—Advisory Board/Consultant: Abbott, McNeil, Eli Lilly, Shire, Novartis, Cortex, Pfizer, Lupin; Research Support: McNeil, Eli Lilly, Shire, Novartis; Speakers’ Bureau: Novartis, Shire Brooke S. Parish, M.D.—Financial Interest/Stock Ownership: 100 shares, Merck. Jeffrey S. Seaman, M.S., M.D.—Clinical Trials: Bristol-Myers Squibb, Cephalon. Paul E. Schulz, M.D.—Speakers’ Bureau: Pfizer, Forest Pharmaceuticals. Jonathan M. Silver, M.D.—Consultant: Novartis. Speaker: Avanir. Dan J. Stein, M.D., Ph.D.—Grant Support/Consultant Honoraria: AstraZeneca, Eli Lilly, GlaxoSmithKline, Lundbeck, Orion, Pfizer, Pharmacia, Rocher, Servier, Solvay, Sumitomo, Wyeth. Michael E. Thase, M.D.—Advisory/Consultant: AstraZeneca, Bristol-Myers Squibb, Cephalon, Cyberonics, Eli Lilly, GlaxoSmithKline, Janssen, MedAvante, Neuronetics, Novartis, Organon, Sepracor, Shire US, Supernus, Wyeth; Speakers’ Bureau: AstraZeneca, Bristol-Myers Squibb, Cyberonics, Eli Lilly, GlaxoSmithKline, Organon, Sanofi Aventis, Wyeth; Expert Testimony: Jones Day (Wyeth litigation), Phillips Lytle (GlaxoSmithKline litigation); Equity Holdings: MedAvante, Inc. Robert J. Ursano, M.D.—Consultant: Abbott, GlaxoSmithKline; Speakers’ Bureau: McNeil. John W. Winkelman, M.D., Ph.D.—Advisory Board/Speakers’ Bureau: Boehringer-Ingelheim, Cephalon, GlaxoSmithKline, Pfizer, Sanofi-Aventis, Sepracor, Schwarz-Pharma, Takeda. Jesse H. Wright, M.D., Ph.D.—The author may receive a portion of profits from sale of software “Good Days Ahead” for computer-assisted CBT discussed in this text. The publisher of the software is Mindstreet, LLC, Louisville, KY. Stuart C. Yudofsky, M.D.—Co-chairman for educational symposium at the 2007 American Psychiatric Association Annual Meeting sponsored by Bristol-Myers Squibb. Phyllis G. Zee, M.D.—Consultant/Advisory Board: Boehrin- ger-Ingelheim, GlaxoSmithKline, Jazz, Sanofi-Aventis, Takeda. The following contributors stated that they had no competing interests during the year preceding submission of the manuscript for the textbook chapter on which their chapter in the present volume is based: Berry Anderson, B.S.N., R.N. José R. Maldonado, M.D., Linda B. Andrews, M.D. F.A.P.M., F.A.C.F.E. Judith V. Becker, Ph.D. A. Kimberley McAllister, Ph.D. Heather A. Berlin, D.Phil., Joel McClough, Ph.D. M.P.H. Barbara E. McDermott, Ph.D. James A. Bourgeois, O.D., Hugh Myrick, M.D. M.D., F.A.P.M. Stephen C. Noctor, Ph.D. Cameron S. Carter, M.D. Fred Ovsiew, M.D., F.A.N.P.A. Prabhakara V. Choudary, Cameron D. Quanbeck, M.D. Ph.D., F.R.S.C. Stephen Rayport, M.D., Ph.D. John F. Clarkin, Ph.D. Phillip J. Resnick, M.D. Cheryl M. Corcoran, M.D., Robert G. Robinson, M.D. M.S.P.H. Scott Schobel, M.D. Laura B. Dunn, M.D. Charles L. Scott, M.D. Marc D. Feldman, M.D. Mark E. Servis, M.D. Ronald E. Fisher, M.D., Daniel W. Shuman, J.D. Ph.D. Daphne Simeon, M.D. Milton J. Foust Jr., M.D. Robert I. Simon, M.D. Albert C. Gaw, M.D. Andrew E. Skodol, M.D. Ralph J. Gemelli, M.D. Stephen M. Sonnenberg, M.D. John G. Gunderson, M.D. David Spiegel, M.D. Katherine A. Halmi, M.D. Sergio E. Starkstein, M.D., Steven P. Hamilton, M.D., Ph.D. Ph.D. Jill D. Stinson, Ph.D. Brian T. Harel, Ph.D. James J. Strain, M.D. Jinger G. Hoop, M.D. Katherine H. Taber, Ph.D., Diane B. Howieson, Ph.D. F.A.N.P.A. Robin A. Hurley, M.D., Daniel Tranel, Ph.D. F.A.N.P.A. Amy M. Ursano, M.D. John A. Joska, M.D., W. Martin Usrey, Ph.D. M.Med.(Psych.), Elizabeth A. Wilde, Ph.D. F.C.Psych.(S.A.) Tara M. Wright, M.D. Paul H. Kartheiser, M.D. Jong H. Yoon, M.D., Ph.D. H. Florence Kim, M.D. Julie S. Young, M.D. Kimberly G. Klipstein, M.D. Sean H. Yutzy, M.D. James A. Knowles, M.D., Ph.D. Susan G. Lazar, M.D. Martin H. Leamon, M.D. Raphael J. Leo, M.D. Muriel D. Lezak, Ph.D. Dolores Malaspina, M.D., M.S.P.H.